2SEVENTY BIO INC2SEVENTY BIO INC2SEVENTY BIO INC

2SEVENTY BIO INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−12.36MXN
Revenue estimate
‪247.24 M‬MXN
Market capitalization
‪3.74 B‬MXN
−74.96MXN
‪−3.70 B‬MXN
‪1.71 B‬MXN
‪47.64 M‬
Beta (1Y)
3.45

About 2seventy bio, Inc.

CEO
William Denise Baird
Headquarters
Cambridge
Employees (FY)
274
Founded
2021
FIGI
BBG013DRGN55
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TSVT is 170.00 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange 2SEVENTY BIO INC stocks are traded under the ticker TSVT.
2SEVENTY BIO INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
TSVT stock is 74.79% volatile and has beta coefficient of 3.45. Check out the list of the most volatile stocks — is 2SEVENTY BIO INC there?
TSVT earnings for the last quarter are −24.40 MXN per share, whereas the estimation was −20.03 MXN resulting in a −21.84% surprise. The estimated earnings for the next quarter are −17.58 MXN per share. See more details about 2SEVENTY BIO INC earnings.
2SEVENTY BIO INC revenue for the last quarter amounts to ‪209.17 M‬ MXN despite the estimated figure of ‪543.43 M‬ MXN. In the next quarter revenue is expected to reach ‪249.78 M‬ MXN.
Yes, you can track 2SEVENTY BIO INC financials in yearly and quarterly reports right on TradingView.
TSVT net income for the last quarter is ‪−965.13 M‬ MXN, while the quarter before that showed ‪−1.25 B‬ MXN of net income which accounts for 22.71% change. Track more 2SEVENTY BIO INC financial stats to get the full picture.
Today 2SEVENTY BIO INC has the market capitalization of ‪3.79 B‬, it has increased by 11.48% over the last week.
No, TSVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TSVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 2SEVENTY BIO INC stock right from TradingView charts — choose your broker and connect to your account.
TSVT reached its all-time high on Nov 10, 2021 with the price of 854.05 MXN, and its all-time low was 97.26 MXN and was reached on May 5, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 274.00 employees. See our rating of the largest employees — is 2SEVENTY BIO INC on this list?
We've gathered analysts' opinions on 2SEVENTY BIO INC future price: according to them, TSVT price has a max estimate of 416.39 MXN and a min estimate of 83.28 MXN. Read a more detailed 2SEVENTY BIO INC forecast: see what analysts think of 2SEVENTY BIO INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 2SEVENTY BIO INC EBITDA is ‪−3.51 B‬ MXN, and current EBITDA margin is −205.62%. See more stats in 2SEVENTY BIO INC financial statements.